AI Article Synopsis

  • The study aimed to assess the effects of Lycium barbarum polysaccharide (LBP) on mice suffering from myelosuppression caused by mitomycin C (MMC).
  • Mice were treated with MMC to induce myelosuppression and then given varying doses of LBP to see if it could help recover blood cell counts.
  • Results indicated that LBP, particularly at higher doses, significantly improved red blood cells and platelet counts in the affected mice, though it did not substantially affect neutrophil levels.

Article Abstract

Aim: To investigate the therapeutic effects of Lycium barbarum polysaccharide (LBP) on mitomycin C (MMC)-induced myelosuppressive mice.

Methods: Mice were intravenously injected with MMC 150 mg/kg for two consecutive days from day -1 to day 0 to produce severe myelosuppression, and then treated by s.c. injections of LBP (100 or 200 mg/kg/day) from days 0 to 6. Blood samples were collected from the tail veins of mice on days 7, 10, 12, 14, 17, 19, 21, 24 and 27, and peripheral white blood cells (WBC), red blood cells (RBC), hemoglobin (HGB) and platelet counts (PLT) etc. were monitored.

Results: LBP at 100 mg/kg (LBP-L) on day 14 and LBP at 200 mg/kg (LBP-H) on days 10, 14, 17, 19 and 21, significantly ameliorated the decrease of peripheral RBC, HGB and hematocrit (HCT) of myelosuppressive mice compared to the control. LBP-L on days 12 and days 14 and LBP-H on days 10, 12, 14, 17, 19 and 21, significantly enhanced peripheral PLT recovery of myelosuppressive mice compared to the control. LBP-H on days 12, 17, 19 and 21, significantly inhibited the increase of mean platelet volume (MPV) of myelosuppressive mice compared to the control. LBP showed no obviously effect on neutropenia induced in mice by MMC.

Conclusion: LBP is effective on peripheral RBC and PLT recovery of MMC-induced myelosuppressive mice.

Download full-text PDF

Source

Publication Analysis

Top Keywords

myelosuppressive mice
20
mmc-induced myelosuppressive
12
lbp-h days
12
mice compared
12
compared control
12
therapeutic effects
8
effects lycium
8
lycium barbarum
8
barbarum polysaccharide
8
polysaccharide lbp
8

Similar Publications

Benzene-induced hematotoxicity enhances the self-renewal ability of HSPCs in Mll-Af9 mice.

Toxicology

January 2025

Key Laboratory of Chemical Safety and Health, National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing, China; China State Key Laboratory of Trauma, Burn and Combined Injury, China. Electronic address:

Patients with benzene-induced leukemia undergo a continuous transformation from myelosuppression to malignant proliferation. However, the underlying mechanisms in this process remain unknown. Our previous studies have shown that the pathways involved in self-renewal capacity of bone marrow (BM) cells in Mll-Af9 mice exposed to benzene for life are significantly activated after severe blood toxicity.

View Article and Find Full Text PDF

Objective: This study aims to investigate the effect of Gallic Acid (GA) on the alleviation of chemotherapy-induced bone marrow suppression, with a comparison to Diyu sheng bai tablets (DYSB) and RhG-CSF.

Methods: A mouse model of bone marrow suppression was established in BALB/c mice using intraperitoneal injections of cyclophosphamide (CTX). All procedures were performed after obtaining ethical clearance from the institutional animal ethics committee.

View Article and Find Full Text PDF

Discovery of Potent and Selective CDK4/6 Inhibitors for the Treatment of Chemotherapy-Induced Myelosuppression.

J Med Chem

January 2025

State Key Laboratory of Natural Medicines, Departemnt of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, China.

Article Synopsis
  • Chemotherapy-induced myelosuppression (CIM) hinders blood cell production, making it a significant issue in cancer treatment.
  • Trilaciclib (TC) is the only FDA-approved CDK4/6 inhibitor that protects bone marrow by stopping the growth of certain cells, and its derivatives show strong potential as effective treatments for CIM.
  • Among these, one derivative displayed excellent inhibitory activity, low toxicity, great selectivity, and effective penetration into bone marrow, indicating it could improve treatment outcomes for individuals experiencing myelosuppression from chemotherapy.
View Article and Find Full Text PDF

Myelosuppression is a serious and common complication of targeted therapy for cancer patients, and there are few studies exploring the efficacy of natural drugs in this condition. Niraparib is a widely used targeted therapy for the treatment of advanced ovarian cancer. As a poly (ADP-ribose) polymerase (PARP) inhibitor, niraparib significantly improves progression-free and overall survival in patients.

View Article and Find Full Text PDF

Bletilla striata polysaccharide-mediated trained immunity drives the hematopoietic progenitors' expansion and myelopoiesis.

Int Immunopharmacol

January 2025

Jiangxi Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Vascular Remodeling Diseases, Jiangxi University of Chinese Medicine, Nanchang 330006, China; National Pharmaceutical Engineering Center for Solid Preparation of Chinese Herb Medicine, Jiangxi University of Chinese Medicine, Nanchang 330006, China; Department of Cardiovascular Sciences and Centre for Metabolic Disease Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA. Electronic address:

Trained immunity represents a functional state of the innate immune response, characterized by enduring epigenetic reprogramming of innate immune cells. This phenomenon facilitates a sustained and advantageous reaction of myeloid cells to subsequent challenges. Bletilla striata polysaccharide (BSP) is the primary active component of Bletilla striata, mainly consisting of mannose and glucose in its chemical structure.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!